Cytokines are hormones that carry information from ceJI to ceH. This information is read from their surface upon binding to transmembrane receptors and by the subsequent initiation of receptor oligomerization. An inftuence on this process through mutagenesis on the hormone surface is highly desirab)e for medical reasons.
Introduction
lnterleukin-4 (IL-4i) controls the growth and differentiation of a number of cells in the immune system (Paul & Ohara, 1987; Paul, 1987, 199f; Jansen et al., 1990; Finkelman et al., 1990 Finkelman et al., , 1991 by acting on receptors of the haematopoietin superfamily (Bazan, 1990a,b; Cosman et al., 1990) . It belongs to a group of smaller cytokines with a molecula.r weight araund 15 kDa. together with interleukin-3, interleukin-5 and the granulocyte macrophage-colony stimulating factor (GM-CSF) (Boulay & Paul, 1992) , and in contrast to, for example, the )arger human growth hormone (hGH), erythropoietin and interleukin-6. IL-4 is secreted by t Author to whom all correspondence should be addressed.
t Abbreviations used: IL-4-, interleukin-4; GM-CSF, granulocyte macrophage-colony stimulating factor; Ig, immunoglobulin; hGH, human growth hormone; NOE, nuclear Overhauser enhancement; NOESY, nuclear Overhauser enhancement spectroscopy; TOCSY, total correlstion spectroscopy; HMQC, heteronuclear multiple quantum coherence spectroscopy; COSY, correlation spectroscopy; TPPI, time proportional pha.se incrementation.
0022-2836/94/140423-14 $08.00/0 c1ass 2 helper T -lymphocytes, mast cells and thymocytes. Its major function is t.he Stimulation of activated B-cells, and the initiation of the proliferation of T lymphocytes, thymocytes and mast cells (Defrance et al., 1987) . IL-4 acts also as an isotype switching factor in conjunction with interleukin-2 and interferon-y in immunoglobuJin-mediated immune responses, discriminating between lgE and IgGI (de Vries et al., 1991; Vitetta et al., 1985; Coffman et al., 1986) . This fact may be exploited for the treatment of allergic diseases (Burstein et al., 1991 ) . Another important action of IL-4 is the induction of cytotoxic CDs-+ T cells, which may serve as a basis for cancer therapy ( Dullens & DeWit, 1991; Tepper et al., 1989 Tepper et al., , 1992 .
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Mutagenesis experiments on IL-4 have been performed in order to characterize the regions important for its activity (Kruse et al., 1991 (Kruse et al., , 1994 Morrison & Leder, 1992) and to find variants with an antagonistic activity profile (Kruse et al., 1992) . The variants showed either reduced binding affinity or were not able to activate the receptor, indicating a separation between binding and signalling. Mutagenesis sturlies of IL-4 related proteins to characterize the receptor binding sites have also been reported, e.g. interleukin-2 (Cantrell et al., published so far Wlodawer et al., 1992; Powers et al., 1992b; Walter et al., 1992a), showing strong structural similarity between IL-4 and others such as GM-CSF (Diederichs et al., 1991; Walter et al., 1992b) , IL-2 (Matt et al., 1992; McKay, 1992) and, to some extent, hGH (de Vos et al., 1992) .
At present, only one IL-4 receptor molecule is fully charact.erized, comprising a. single polypeptide chain of ~ 800 amino acid residues (Mosley et al., 1989; Galizzi et al., 1990; Harada et al., 1990; Idzerda et al., 1990) . It occurs at the relatively low flgure of 150 to 2500 molecules per target cell (CabriJlat et al., 1987; Park et al., 1987) . A single dissociation constant of ::::: 100 pM has been determined for the receptor-cytokine interaction. The IL-4 receptor is evolutionarily related to the large family of haematopoietin receptors, including receptors (or receptor subunits) for interlenkins 2, 3, 5, 6 and 7, for GM-CSF and G-CSF and also for erythropoietin, growth hormone and prolactine (Bazan, 1990a,b; Cosman et al., 1990) . Recently, a second IL-4 receptor, which shows low affinity binding to IL-4 has been isolated from pre-B cells, but there is only limited sequence data available (Fanslow et al., 1993) .
The initiation of the signal transduction chain by the lymphokines is thought to proceed through oHgomerization of at least two Jike or two unlike transmembrane receptor molecules, where the hormone interacts with the outer cell components, and the signal is transmitted to inside the celJ upon oligomerization (Bazan, 1990a; Watowich et al., 1991; . The positions ofthe receptor binding sites on the lymphokines deduced from mutagenesis studies were supported by the structure of the hGH receptor complex (de Vos et al., 1992) in which it is seen that one of two like receptor molecules binds to the A-C face of the fourheJix bundle, and the other to the A-D face. For interleukin-3, interleukin-5 and GM-CSF, it is known that an a-subunit of a heterodimeric receptor binds specificaJJy to the hormone, and that the ß-subunit forms a complex only with the hormone/ IX-chain adduct (Hayashida, 1990; Fukunaga et al., 1990; Kastelein & Shanafelt, 1993) . In the past it has been proposed that IL-4 mediates the dimerization of two like receptor molecules, as has been established for the growth hormone (Paul, 1991; Bamborough et al., 1993; Wlodawer et al., 1993) .
However, the formation of homodimers has not yet been demonstrated for the high-affinity IL-4 receptor reported to date. Also, with the advent of a second IL-4 receptor (Fanslow et al., 1993) , a heterooligomeric system becomes more Jikely.
In the light of this discussion and with the aim of designing further potential antagonists, the following issues are addressed in this paper: (1) a characterization of the major epitope responsible for signaHing through the investigation of the varian ts Yl24G and Yl24D; (2) the identiflcation of further residues building the epitopes responsible for receptor binding; and (3) a characterization of the mode of receptor oligomerization, in particular, with respect to the potential formation of homo-or heterodimeric receptor complexes.
Thus, the structure of IL-4 and the results of the investigations of the variants are discussed in terms of possible modes of hormonefreceptor interactions. This discussion is based on the strong sequence similarity between the known IL-4 receptor and the huinan growth hormone receptor, for which structural data are available.
Materials and Methods
A method was employed for the structural investigation of the wild-type IL-4 and the variants Y124D and Yl24G which does not rely on 13 C-labelling as commonly used for such proteins (Powers et al., 1992a; Garrettet al., 1992) . Jnstead, a set of 15 N-NOESY HMQC, 15 N-TOCSY HMQC (Marion et al., 1989 ) and 3D-TOCSY-NOESY (Oschkinat et al., 1990) spectra was used for the assignment of the resonances and the interpretation of the NOESY spectra. Most of the distances were determined from short mixing time NOESY spectra, enabling a more precise quantification of the NOEs. This approach was chosen to allow the investigation of those variants which are only expressed at low Ievels in Escherichia coli. The disadvantage of this method isthat a smaller number of NOE is available in cases of severe spectral overlap, but this may be partly compensated for by the more precise measurement of the NOE which are available. Three samples of wild-type IL-4 were prepared. Two samples contained unlabelled IL-4, one was uniformly 15 N-labelled. Buffer conditions were 45 mM Na0Ac-d3, I0% 2 H 2 0/90%H 2 0, 0·2o/ 0 NaN 3 , at pH 5·3. One unlabelled sample contained 10 mg in 600 Jll, the 15 N-Iabelied sample contained 14 mg IL-4 in 600 IJI butfer. The second unlabelled sample contained 40 mg IL-4 in 1·2 ml with the same buffer, but at pH 5·5 and was measured in a 8 mm NMR tube. More dilute samples were prepared of the variants Yl24G and Yl24D. For the variant YI24G, 18 mg of protein were dissolved in 1·2 ml of buffer, and 12 mg in 600 J.d buffer for the variant Y124D.
(b) NM R measurement:~ All measurements were performed on a Bruker 600 MHz AMX spectrometer at 303 K, if not specified otherwise. TPPI was applied to achieve quadrature detection in the virtual dimensions. The 8 mm samples were measured on a commercial 8 mm selective 1 H probe (Bruker). The wild-type sample, in the 8 mm tube, was used to measure a set of 2D-spectra: COSY (Aue et al., 1976) , TOCSY (tm=27 ms) (Griesinger et al., 1988) , NOESY (tm = 10, 20 ms, with a long relaxation delay), all with presaturation 1 NOESY (1 111 = 80 ms) w:ith a jumpreturn read pulse (Jeener et al., 1979) , and a 3D-TOCSY-NOESY {tmTOCSY =27 ms, tmNOESY = 100 ms} spectrum. The 2D spectra were typically recorded with a spectral width of 8333Hz, 1024/2048 data points in t 1 /t 2 , and using a B1-field of 20 kHz for the TOCSY experiments. Zero quantum coherences were not suppressed in the NOESY spectra. The TOCSY-XOESY spectrurn was processed in subcubes of the 512/512/512 data points used for t.he whole spectrum. T~inear prediction was applied to predict data. points up to double the number of those recorded, and extensive baseline correction was applied to all 3 dimensions. The heteronuclear 3D-spectra were typically processed in subcubes of the 1024/256/1024 data points used for the full spectrum.
The 20 ms NOESY spectrum used for the quantitative evaluation was processed with the application of a Lorentz-to-Gauss transformation and zero-filled up to 4096 data points in both dimensions to obtain optimal line shapes. Baseline corrections were applied using a polynomial of order 5. Cross peaks were integrated using the program AURELIA (Neidig et al., 1990) . As an example for the quality of the 20 ms NO.ESY data, the 3. 
(c} Spectral assignments
The assignment of the spin systems and the sequential assignments were obtained by conventional evaluation of COSY, TOCSY, and 15 N-NOESY-HMQC spectra tagether with the 15 N-TOCSY-HMQC spectrum (Marion et al., 1989) . The evaluation of the TOCSY-NOESY spectrum helped to complete the assignment. Approximately 60 NOE of the Na:N-and aNN-type (Oschkinat et al., 1990) were used for the sequential assignment, supplementing the data from the heteronuclear spectra. The results obtained werein line with the assignments reported in the Iiterature (Redfield et al., 1991; Powers et al., l992b) except that the assignment of the methyl group proton resonances of A49 was very differenttothat obtained by Powers et al. In our spectra, the proton methyl signal occurs at a chemical shift of 0·28 p.p.m. It was assigned by means ofCOSY, TOCSY and NOESY cross peaks, and showed an unexpectedly large line width.
(d) Assignment of NOE
The NOE involving the amide protons were largely assigned using the 1 5 N -separated 3D-spectra. Other NOE were assigned with the help of a 3D-TOCSY-NOESY spectrum, which was evaluated using F tfF 2 -slices (TOCSY slices}. It turned outtobe most practical to scan the NOESY spectrum along the F 2 -axis and to evaluate for each p.p.m. value the corresponding slices from the 3D spectrum with the same F 3 -co-ordinate. An NOE with a certain F 1 -frequency in the 2D-spectrum was then assigned by means of the 3D cross peaks in the F 1 /F 2 slice with the same Frfrequency. As a result, always one partner involved in the NOE (the one precessing in t 1 of the NOESY sequence) was characterized by 2 frequencies. In this way, assignments from the 2D TOCSY spectrum were used to assign the 3D-spectrum and the 2D NOESY. The assignment was unique when the signal in F 3 (or F 2 in the NOESY) was not overlapped by others in the 1D-spectrum, and the used TOCSY cross peak not superimposed by others in the 2D spectrum. In the case of overlapping signals in F 3 , slices taken at the F 3 position of the partner involved in the NOE were inspected. It is in fact the symmetrical NOESY peak which is then observed to be dispersed into the third dimension by a coupling partner. This situation is similar to that which oecurs during the evaluation of 13 C-NOESY HMQC spectra. A slice of the 3D-TOCSY -NOESY spectrum taken at the F 3 -frequency of the V29 methyl group at 0.61 p.p.m. and the whole aliphatic region in F 1 /F 2 is shown in Figure 2 . The signals belanging to the high-tield methyl group of V29 show a number of NOE, which are mostly to Leul09, as indicated.
(e) Quantijication of NOE
A build-up series of NOESY spectra was recorded to monitor the NOE curve for different types of NOE, e.g. NOE between geminal protons or between protons in the aromatic rings of the tyrosines. lt turned out that a linear interpretation of the amplitudE>,s was still possible in the spectrum recorded with a mixing time of 20 rns. The NOE from the 20 ms NOESY spectrum were then calibrated with rE>,spect to averaged reference NOE of the sametype (e.g. NH-aliphatic, aliphatic-CH 3 , etc). The following NOE were chosen as references: NOE between the amide protons in the side-chains of glutamine or asparagine; NOE inside the aroma.tic ring of the tryptophane; the NOE between two cPH, NOE between a'H and methyl groups in alanines or CPH and methyl groups in threonines; the NOE between arornatic protons in tyrosines; and the NOE between the methyl groups in valine or leucine. The largest distances observed varied from 3·0 A (NH-NH type) to 4·2 A (aromatic-methyl NOE).
The error on the determined distances is composed of a statistical error due to spectral noise or artifacts, and systematical errors. For the latter, 2 major sources are expected: the effective correlation times for the internuclear vectors should vary over the protein, and the "initial rate approximation" could already be violated for some types of reference NOE. The variation of the local correlation time was therefore determined for a number of well-resolved reference NOE (around lO) for each type.
The standard deviation was below O·l A except in one case; only the references taken from alanines and threonines showed a !arger standard deviation ( <0·15 A). This is an unexpected result, as at least" the side-chains of the asparagines and glutamines were expected to show different modes of motion. It was interpreted as an indication that the effective correlation times for the internuclear vectors are relatively similar for most of the residues in this 4-helix bundle protein, inclusive of the loop regions. A quenching of NOE was therefore not expected to be a major problern and lower bounds were used in the calculations. However, this approach is applicable only in this case due to the rigidity of the overall structure, where even the loops connecting the helices show only an intermediate degree of fiexibility. Some classes of reference NOE were compared with each other to check whether the initial rate approximation was already violated. However, only negligible deviations were found.
For shorter distances ( < 3 A} between backhone atoms (NH-NH, C 11 H-NH} error Iimits of ±0·15 A ·were used.
These relatively narrow error margins were chosen because the values of the reference NOEs showed a small standard deviation and these kind of distances should be less affected by local motions. For the other distances error Iimits ranging from ± 0·21 A (for distances below 3 A not involving methyl groups) up to ±0·35 A were used. The amplitudes of the cross peaks which could not be integrated due to partial spectral overlap were estimated by comparison with non-overlapped peaks. Much larger error Iimits were used for those, ranging from ±0·4 A to ±0·6 A. A number of constraints were taken from the 15 N-NOESY-HMQC spectrum or from the NOESY spectrum with a mixing time of 80 ms; they were used in the calculations as upper Iimits only, and generous error margins were used. In total, 583 integrated and 248 estimated NOE were taken from the 20 ms NOESY spectrum, and 197 upper Iimit NOEs were taken from the spectra with Ionger mixing times.
(f} Structure calculation
The structures were calculated using the program XPI..OR (Brünger, 1992) . Prior to each calculation, an individual extended starting structure was generated. Apart from the NOE Iist, 120 mild dihedral angle restraints based on coupling constant information (J HH TOCSY experiment) (Willker & Leibfritz, 1992) were included in the calculation. No hydrogen bond constraints were used. Standard 2-step simulated annealing protocols were applied (Nilges et al., 1991) including floating assignment. The first step consisted of 25,000 steps hightemperature dynamics (timestep 0·005 fs) at 2000 K, followed by a ·cooling to 300 K and then energy minimization. In this phase, disulphide bonds were removed and substituted by appropriate NOE. The NOE forces were all scaled down at the beginning, and then slowly increased. The second step of the protocol consisted again of a simulated annealing period (8000 steps at 2000 K, timestep 0·005 fs), followed by 10,000 steps of cooling, in which the repulsive non-bonded interactions were scaled up to a normal Ievel, and disulphide bonds included. A total of 70 structures of the wild-type were calculated, of which 32 were selected on the basis of the lowest global and NOE energy violations (770 and 450 kcaljmol A 2 , respectively). In all, 40% of the selected structures showed no NOE violations }arger than 0·4 A, for all the other selected structures 1 or 2 violations in different places were observed. (Redfield et al., 1992) . A minimized average structure of the 32 calcuJated structures shown in Figure 3 was compared to the average structures of the two NMR investi- 
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gations available from the Brookhaven Data Bank, liTL , and IBBN (Powers et al., 1993) , as well as to a crystal structure, 1RCB (Wlodawer et al., 1992) on the basis of r.m.s.d. values (Table I) . On the whole, the comparison of the NMR structures with each other and with the crystal structure IRCB shows a similar Ievel of accuracy for the three NMR structures. Com paring backhone atoms (C' ,G',N) for the residues 5 to 125, the three NMR structures diverge by values of l·30A (lBBN), l·58A (our structure), and 1·59A (IITL) from the X-ray structure (IRCB). Our structure shows an r.m.s.d. of 1·98 (liTL) and 1·68 ( l BBN) to the other NMR structures. There are two individual regions which merit some closer inspection, that is the region with the tryptophan, whose position is highly dependent on the assignment of A49, and the region araund tyrosine 124. The region 88 to 98 of our structure shows a small, but significantJy smaJler r.m.s.d. to the X-ray-structure lRCB when backhone atoms are compared, but a much better definition, when all heavy atoms are compared (Table l ) . The reason for this is the considerable nurober of NOE between A49 and W91 found in our spectra. In fact, the position of the side-chain of W9l is exactly the same in our structure as in the X -ray structure. The structure araund Yl24 is important for the initiation of signal transduction and is hence a potential target for drug design. The area around this tyrosine (5--.14, ll6--+l25) deviates in our structure by 0·71 A from the X-ray structure, when backhone atoms are compared, and by 1·79 A, when all heavy atoms are compared. The other two NMR structures show similar deviations from the X-ray structure (Table I ). The side-chain of Yl24 is posi- tioned in the contact area between helices A and D, exposing part of the aromatic ring (approximately 40%), and the OH group, to the solvent, forming a hydrophobic region on the surface of the protein.
The position of Yl24 is defined by hydrophobic interactions with the side-chains of L7 and Ill, the latter also showing some solvent accessibility. On the surface around the site of Y124, a number of hydrophilic residues are positioned, i.e. Rl21, 8125, and Q8. There is a considerable number of NOE involving Yl24 (Figure 4 , Table 2 ). Its ring is partly protec~d by the side-chains of Ill and Rl2l. The side-chain of Rl2l shows NOE between its C"H and the C 6 H methyl group of 111, which defines the position of its CIZ-C 6 -fragment. The guanidinium group, however, does not show any NOE to Yl24, which would be expected from the X-ray structure.
In particular, the NeH of R121 and the aromatic protons of Yl24 should show strong NOE if a rigid structure, as present in the X -ray structure involving a hydrogen bond between Rl21 and Q8, The intensity of the strongest NOE between the indicated residues is given (s, strong; m, medium; w, wea.k; sfm, wfm, at the transit.ion point; 1, not available due to spectral overlap; , not observed, proba.bly for rea.sons of different signalfnoise.
would exist in solution. There are a number of NOE defining the orientations of helices A, B, C and D with respect to each other in this a.rea (Table 2) . These are the potential indicators for structural changes in the variants.
(b) Variants Y124G and Y124D
The variants Yl24G and Yl24D were investigated to determine the nature of the structural changes resulting from these Substitutions. Thc NMR spectra of both variants show similar chemical shifts for most of the residues compared to the wild-type, suggesting strong similarity in their overall structures. For both variants, larger chemical shift changes were only observed towards the C and N terminus. T n fact, chemical shift deviations smaller than 0·1 p.p.m. are observed for the residues II to 120 of Yl24G, indicating that no large-sca.Je structural changes are present. Similar observations were made for Yl24D. However, in the region of the substitution greater effects on the chemical shifts were observed. This is expected for the Substitution of an aromatic side-chain as it has a ]arge anisotropic effect.
The local NOE pattern of the regions I to 9 and 120 to 124 in the variant Yl24G shows the conservation of oc-helical structures around the substitution site. The secondary structure appears to be identical to that of the wild-type, where helix A starts at 15, and the end of helix D can be located at 8125. This is indicated for helix A by the sequential NOE of the type NH;NH;+t• as weil as by the presence of the NOE ofthe type a 1 NHi+J• involving 15 and Q8 ( Figure 5 ). Helix D extends up to 8125, as can be concluded from the NHiNH 1 + 1 NOE observed, and from a number of Iong range NOE which are also found in the wild-type (Figure 4) , involving for example L7 and G 124 ( Table 2 ).
The variant Y124D shows a pattern of secondary structure ( Figure 5) residues 121 and 124 and those of the type NHiNHi+ 1 between residues 124 and 125 shows that helix D also extends up to Sl25 in the variant YI24D. The NOR between L7 and Dl24 are also observed, although these are somewhat weaker. All other long range NOE are of comparable size ( Table 2) .
Discussion
The secondary and overal1 tertiary structure in both variants is not . perturbed, therefore the changes in the activity profile of the mutants Yl24G and Yl24D are related to interactions of the receptor with the tyrosine side-chain and its environment, potentially RI21 and Sl25. This is supported by the activity pattern of the Yl24 variants. The ability to stimulate cell proliferation drops within the sequence WT, Yl24F, Yl24H> > Y124G, YI24K, YI24N> > Yl24D (Kruse et al., 1992) . The fact that variants with aromatic acids in place of Yl24 show nearly wildtype activity and the conservation of the structure in the YI24G and Y124-D lrariants suggests the importance of a hydrophobic region formed by part of the aroma.tic ring of YI24 for receptor binding. The mutations do not infl.uence the A-C site of the hormone, which explains the unaltered binding properties. These results are in contradiction to those reported in recent investigations (Bamborough et al., 1993; Powers et al., 1993; Wlodawer et al., 1993 ) . They proposed tha.t the role of Yl24 is to stabilize the surrounding of the helical structure and that the changes in the activity profile observed for YI24G and Yl24D are due to a loss of structural integrity in this region. In support of this, mechanisms for breaking a helix through glycine or aspartic acid are known, and a docking of the high-affinity IL-4 receptor model to the A-D site of the hormone did not Iead to contacts between the receptor and the environment of Yl24.
The functionally important region of the structure, the putative recognition site(s) for the receptor(s), is given by the structurally well defined D-A-C face of the hormone. This is based on the analogy to the growth hormone, and the modified activity of the mutants E9Q/K (helix A) and R88Q/D (helix C), which showed reduced binding activity (Kruse et al., 1994) ; the variant Yl24D (helix D), which showed a strongly antagonistic activity, and the mutants Rl2ID, Yl24G and SI25D, which were only partial antagonists. The mutations HIQ, D4N, E26Q, E4IQ, E43Q, R47Q, R53Q, H59Q, K61Q, R85Q, El03Q, E114Q, Kll7Q, Kl23D, and Sl28D showed no effect. Figure 6 shows a view of the D-A-C helix interface. Amino acid substitutions without any effect are shown in blue, those which resulted in reduced binding activity are colonred yellow, and those which Iead to an antagonistic activity profile are coloured red. In light of the model of receptor oligomerization, the A-C face (Figure 6(c) ) would . Sequence alignment of (a) IL-4 and GM-CSF, and (b) IL-4 and hGH derived from a structure comparison using the program WHATIF (Vriend & Sander, 1991) . In the case ofthe compa.rison ofiL-4 and hGH, an automatic best fit of the st.ructures was generated by maximizing the superposition of common structural elements (Vriend & Sander, 1991 ) . Forthose residues which were structurally not further apart from each other than 2·0 A, a maximum of sequence identity (7%) was obtained. Further support for the sequence alignment deduced from the superposition of the structures is given by the alignment offunctionally important residues, i.e. Nl2 ofhGH aligns with E9 of TL-4-, as weil as then be primarily responsible for the binding of the first receptor molecule, whereas the A-D face (Figure 6(a) ) would bind the second one, initiate dimerization of the receptor, and hence be responsible for the signal. Surprisingly, the amino acid Substitutions leading to an altered activity profile are located in relatively narrow areas.
The mutations on the A-C side of the hormone Iead to interesting conclusions concerning the inßuence of charges and of the electrostatic properties of the surface of the protein. The strongest effects for the E9 and R88 mutants are observed when the charge is reversed. The introduction of a glutamine at either position Ieads to a noticeable, but not dramatic, effect on the J!JC so value. I t rises from 200 pM to a value of 2000 pM in the case of R88 and 1400 pM for E9. The effect becomes dramatic upon charge reversal (EC 50 =260,000 pM for E9K and 69,000 pM for R88D) (Kruse et al., 1994) . A similar effect is observed for the substitutions of Yl24, where the introduction of a negative charge Ieads to the strongest antagonist. An inspection of the electrostatic properties of the protein surface reveals a very uneven distribution of charged amino acids; the solvent-exposed side of helix C contains many positively charged residues (K77, R81, K84, R85, and R88) (Wlodawer et al., 1992) , while a patch of negatively charged residues is observed in the region around the ß-sheet, the beginning of helix D, and the end of helix A. The negatively charged region is made up of the residues El9, E26, D31, EllO and Ell4. A comparison of the electrostatic properties of IL-4 with those of other cytokines allows conclusions to be drawn concerning whether two like or two unlike receptor molecules may be bound by the hormone (E. Demchuk, T. Müller, W. Sebald, H. Oschkinat and R. Wade, unpublished) . In fact, the known lL-4 receptor which shows a nurober of negatively charged residues in the contact area should bind only to the A-C face of IL-4.
The results of the mutation experiments can be compared to other lymphokines by a structure and sequence comparison between lL-4, GM-CSF and hGH. A comparison of hGH and IL-4 is of special interest, as a number of point mutational data on hGH are available (Cunningham & Wells, 1989 , 1991 which may be compared to the mutational data on IL-4, and the structure of the hGHfreceptor complex provides a molecular. basis for examining hormone-receptor interactions. A comparison seems justified, despite the difference in size between the contact surface of the hGH (4500 A 2 ) and IL-4 (2400 A 2 ), since the A-C face of the IL-4 is of similar size to that in hGH, and the A-D face of IL-4 matches the size of the area important for activity on the A-D side of hGH as defined by site-directed mutagenesis experiments (Cunningham & Wells, 1989 , 1991 .
The comparison of all three structures shows that the individual helices have rather different lengths but the angles between helices A, C and D are very similar. The interhelix angles between these three helices and helix B, which seems not to be important for receptor binding, vary to a larger extent.
Comparison between IL-4 and GM-CSF ( Figure  7(a) ) shows first of all the major role played by E9 in TL-4 and E2l in GM-CSF (Meropol et al., 1 992), which in fact are Jocated in the same place in the aHgned sequences. For other mutagenesis experiments on GM-CSF the effects are more difficult to explain in terms of receptor-hormone interactions, because they involve either tripeptide deletions (Shanafelt & Kastelein, 1989) , the synthesis of chimeric mouse/human proteins (Kaushansky et al., 1989) or proline scanning (Altmann et al., 1991) . In all cases, larger structural rearrangements are expected. An example is the comparison of mutations on helix C, where the IL-4 mutants R88Q/D show very different binding properties, and the substitutions R85Q and W91R are rather neutral. The experiments with the chimeric proteins on GM-CSF show that residues in the region 78 to 94 (GM-CSF numbering) (Kaushansky et al., 1989) are responsible for the activity, but the active site cannot be localized further.
An independent comparison between hGH and IL-4 (Figure 7(b) ) may be made on the basis of results from mutational studies (see symbols above the sequence of hGH and below the sequence of IL-4) and on the basis of the residues structurally involved in receptor-hormone interactions (de Vos et al., 1992) . The latter are indicated within the sequence of hGH. The mutational studies firstly demonstrate that substitutions on the D helix in hGH affect the binding affinity (Cunningham & Wells, 1989) , whereas mutations on that side in IL-4 Iead to antagonistic activity, and vice ver Ba for the A-C face. This indicates that the hormonesbind the receptor molecu1es in a different order. Despite this difference, similar interactions with the receptor molecules seem to occur. The binding affinity of Ell9 with R88, Rl78 with Rl21, and Ql81 with Yl24 of hGH and IL-4. The residues directly involved in receptor binding and the residues found to be important in mutational studies are indicated. An automatic alignment did not yield the highest possible sequence homology for IL-4 and GM-CSF. Therefore, the alignment was performed manually by superimposition of the structures so that the residues not further away from each other than 2·0 A in both proteins showed a maximum sequential identity. Simultaneous1y, a good fit was obtained for the common motif in the 2 structures made up by the helices A and D, the ß-sheet, and the loops connecting the 2 helices and the sheet. The residues in the superimposed structures which show an r.m.s.d. less than 2·0 Aare printed with a reduced spacing. The mutational data on hGH and IL-4 are included aa symbols above or below the sequences. Circles indicate mutations tha.t Iead to reduced binding properties, squares indicate sites where mutations produced an antagonistic activity. For hGH, the residues directly involved in receptor binding are indicated within the sequence by circles (first binding receptor molecule) and squares (second receptor molecule). The helical regions are shaded.
IL-4 to its known receptor is strongly affected by the residues E9 and R88Q, and the corresponding residues Nl2 and Ell9 play a major role in hGH (de Vos et al., 1992; . Unexpectedly,,substitutions ofR85 in IL-4 have no effect, although the corresponding residue in hGH (Dll6) is directly involved in receptor bindingvia a salt bridge and its replacement by alanine shows )arger effects on the activity than a substitution of Ell9. The roJe of the N terminus may be different for both proteins, as the Substitution HJQ in IL-4 showed no effect, whereas I4 variants of hGH showed large differences in activity compared to the wild-type.
The epitope on the D-helix defining the area primarily important for the binding of the first receptor molecule in hGH (Cunningham & WeHs, 1989 ) is in a similar position to the site in IL-4, where mutations Iead to an antagonistic activity. In fact, the substitution of Rl21 in IL-4 leads t,o a result equivalent to the substitution of Rl78 in hGH. The effects observed for the substitution of Cl82 in hGH are in agreement with those observed for 8125 in IL-4. The strong effect observed for Yl24 in IL-4 has no correspondence in hGH, which is surprising considering the localized structural effect of the mutations in IL-4 (see above). In the same manner, the neutrality of the substitutions of K 117 in IL-4 is not expected from the comparison with hGH. However, substitution with a negatively charged residue would be expected to show great.er effects. An estimate of the interactions of two receptor molecules of the haematopoietin type with IL-4 can be obtained from comparison with the hGHfreceptor complex. The site of hGH which binds the first receptor molecule is the A-D face involving the residues HIS and F25 on helix A, and RI67, Kl68, Dl71, Tl75, Rl78, and CI84 on helix D, neglecting the residues located in the insertion. In IL-4, the residues EllO, Nlll, Ell4, and Tll8 should interact with a receptor molecule in addition to Rl2l, Yl24 and 8125, and hence be potential candidates for generating antagonis~ic activity. Appropriate substitutions of Nl5 m IL-4 could have similar effects. The substitution Ell4Q, however, did not lead to a change in activity of IL-4. The A-C face of hGH contributes the residues T3, I4, L6, Nl2, Ll5, Rl6, Rl9, Q22, YI03, Dll6 and Ell9 to receptor binding. The alignment of the hGH and IL-4 sequences provides an explanation for the finding that the IL-4 mutants E9K. and R88D ~~ow strongly reduced binding propert1es. In add1t10n, appropriate substitutions of K12, T13, 816, El~, and R85 should show similar effects. The results allow some conclusions to be made concerning the mode of receptor binding of IL-4. Firstly, the A-C face in IL-4 binds first to a single molecule of the known TL receptor. 8econdly, the strong similarity of the A-D side, including the ß-sheet, in IL-4 and GM-CSF is striking. This could mean that a second receptor molecule, related to the GM-CSF receptor, binds to that side of TL-4. Support for this argument comes from the different distribution of charged residues on both sides of the hormone. The surface of helix C is strongly dominated by positively charged residues, and a large negative region is observed on the A-D side in the area of the ß-sheet, the loops to the helices A and D, and at the beginning of helix D. This suggests that the binding of IL-4 to the known IL-4 receptor, which has negatively charged residues in the proposed binding area (Fernandez-Botran & Vitetta, 1990; Bazan, l990c) to this face on IL-4 is implausible.
